Dr. Cross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
685 W. Baltimore Street, Suite 8-00
Baltimore, MD 21201Phone+1 410-706-6012Fax+1 410-706-4330
Education & Training
- University of MarylandFellowship, Gastroenterology, 2004
- University of MarylandResidency, Internal Medicine, 1997 - 2001
- University of Pittsburgh School of MedicineClass of 1997
Certifications & Licensure
- MD State Medical License 2000 - 2026
- PA State Medical License 2020 - 2022
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (AGAF) American Gastroenterological Association, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis Start of enrollment: 2008 Jan 01
- The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis Start of enrollment: 2008 Oct 01
- Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program.Andres J Yarur, Michael V Chiorean, Jessica R Allegretti, Raymond K Cross, Christina Ha
Inflammatory Bowel Diseases. 2024-12-13 - 2 citationsFactors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD.Madeline Alizadeh, Kiran Motwani, Bernadette C Siaton, Ameer Abutaleb, Jacques Ravel
Inflammatory Bowel Diseases. 2024-11-04 - Coronary artery calcium score for cardiovascular risk assessment in inflammatory bowel disease - Data from first pilot prospective study.Omair Iqbal, Harini Shah, Antonio Sosa, Jacquelyn Kulinski, Raymond K Cross
Digestive and Liver Disease. 2024-11-01
Journal Articles
- A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)David A Schwartz, Mahrukh Riaz, Raymond K Cross, Seema A Patil, Sandra M Quezada, Barathi Sivasailam, Sara N Horst, Miguel Regueiro, Leyla Ghazi, Nature
- Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s DiseaseSeema A Patil, Raymond K Cross, Digestive Diseases and Sciences
- Correction to: Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex LifeMichael D Kappelman, Swathi Eluri, Robert S Sandler, Millie D Long, Raymond K Cross, Digestive Diseases and Sciences
- Join now to see all
Authored Content
- An Update on Safety of Janus Kinase Inhibitors in Treatment of Patients with IBDJune 2024
- Steroids: Never or ForeverDecember 2022
- A Dog Is a Child's Best FriendMay 2022
- What Can I Eat?June 2021
- Questions You May Have About Your IBD Patients and COVID-19December 2020
- How Gastroenterologists Can Help with Comprehensive Patient CareJanuary 2020
- How Gastroenterologists Can Help with Comprehensive Patient CareJanuary 2020
- Join now to see all
Press Mentions
- IBD Drive Time: David Hudesman, MD, on Work Productivity in IBDSeptember 19th, 2024
- It’s Time to Man up and See a DoctorSeptember 17th, 2024
- Raymond Cross, MD, on Drug Positioning in Crohn's DiseaseJuly 19th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: